Canada’s New Outdoor Grow Regulations Create New Risks, Opportunities
Ryan Allway
August 3rd, 2018
Exclusive, News, Top Story
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide later this year. Last month, the government surprised many industry analysts and participants by legalizing the outdoor cultivation of cannabis in an attempt to lower prices, increase global competitiveness, and better compete with black market products.
These developments have had a mixed effect on licensed producers. While many licensed producers have already invested hundreds of millions of dollars in indoor grow facilities, others like SpeakEasy Cannabis Club Ltd. (CSE: EASY) have shifted their focus to include outdoor cultivation. Investors may want to consider diversifying their portfolio across both types of cultivators to realize the benefits of each option.
Canada’s Controversial Outdoor Grow Decision
Canada, like most jurisdictions where cannabis has been legalized, has historically required cultivators to grow their crops in tightly regulated indoor facilities. Licensed producers invested billions of dollars in brand new indoor cultivation facilities in compliance with the country’s original cannabis cultivation regulations. The high cost of these facilities has translated to relatively high costs for products that ultimately hit consumers.
The Canadian government surprised many licensed producers and industry analysts by legalizing outdoor growing in the final cannabis legalization rules. The move was designed to help lower cannabis prices to better compete with black market products, while ultimately positioning the country as a leading supplier to the global market. Unfortunately, that leaves many licensed producers that spent billion on indoor facilities in a bind.
“Our decision to allow outdoor grow under strict rules is the result of extensive consultations and will contribute to creating a diverse and competitive legal cannabis industry with the ultimately goal of displacing the illegal market,” said Thierry Belair, spokesperson for Ginette Petitpas Taylor, the Canadian Health Minister, according to The Globe and Mail.
Despite the industry’s concerns, there could be room for both types of growing in the modern cannabis industry. Outdoor cultivation could become critical for the supply of extract products, such as cannabidiol (CBD) and tetrahydrocannabinol (THC) oils, which are used in vape and edible products. Meanwhile, indoor greenhouse operations could remain ideal for creating highly specific medical or high-potency cannabis strains.
Investing in LPs Focused on Outdoor Cannabis
Most licensed producers are focused on indoor cannabis cultivation since that has been the status quo since the MMPR regulations were introduced years ago. With outdoor cultivation legalized last month, there are only a handful of companies that are actively pursuing or adjusting their plans to grow cannabis outdoors. Investors may want to consider these companies as a way to diversify their portfolio across indoor and outdoor opportunities.
SpeakEasy Cannabis Club Ltd. (CSE: EASY), a late-stage ACMPR applicant, became one of the most high-profile companies to shift its focus to outdoor production. On August 1, the company announced plans to begin work on its first 60 acre outdoor plantation and processing facility in Rock Creek, British Columbia. The 2.6 million square foot outdoor production area would make it one of the largest licensed producers in Canada.
“The recent release of regulations allowing outdoor production is a dream come true for us,” said SpeakEasy CEO Marc Geen. “It has always been our plan to grow outdoors on a large scale, but we did not expect regulations to allow it to happen this soon. The climate here in Rock Creek is absolutely perfect for growing cannabis outdoors and we are thrilled at the opportunity to begin as soon as possible.
The company anticipates that development costs will be less than $10.00 per square foot. By comparison, indoor facilities can cost 20 to 30 times as much to build. Its production costs are also expected to be about one-quarter of the cost of indoor facilities, which range from $1.00 to $1.75 per gram for greenhouse production and $2.00 or more per gram for indoor facilities that are more tightly controlled than greenhouses.
Looking Ahead
SpeakEasy Cannabis Club Ltd. (CSE: EASY) is a late-stage ACMPR applicant that could become one of the largest cannabis producers in the country with 290 acres of land and plans to build a 60 acre outdoor cultivation footprint starting next Spring. Investors may want to consider the stock as a way to diversify their holdings from indoor cultivators to include outdoor cultivators that could benefit from lower development and production costs.
For more information, visit the company’s website at https://speakeasygrowers.com/.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
CB Therapeutics, Inc. is a biotechnology company focusing on the innovative production of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
